TIFFANY BREWER: Open Payments
NPI 1881464014 · FLORENCE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$415 in 23 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $223 · 2025 $415
Food & beverage: $415
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $81 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $79 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Novo Nordisk Inc | 2 | $37 |
| Amgen Inc. | 2 | $36 |
| Exact Sciences Corporation | 2 | $34 |
| Lilly USA, LLC | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $14 |
Products named: CAPLYTA, BREZTRI, Wegovy, OTEZLA, ELIQUIS, Cologuard Collection Kit, MOUNJARO, PREVNAR 20.
Industry payments across AL — which companies pay providers there.
